BofA Securities Downgrades Humana (HUM) to Neutral, 'Rebasing expectations on deteriorating reimbursement'
Tweet Send to a Friend
BofA Securities analyst Kevin Fischbeck downgraded Humana (NYSE: HUM) from Buy to Neutral with a price target of $342.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
